Clear Creek Financial Management LLC Has $525,000 Stake in CME Group Inc. (NASDAQ:CME)

Clear Creek Financial Management LLC raised its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 4.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,378 shares of the financial services provider’s stock after acquiring an additional 107 shares during the quarter. Clear Creek Financial Management LLC’s holdings in CME Group were worth $525,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in CME. Salomon & Ludwin LLC bought a new stake in CME Group during the 1st quarter worth approximately $28,000. Y.D. More Investments Ltd acquired a new stake in shares of CME Group in the second quarter valued at $36,000. McClarren Financial Advisors Inc. raised its holdings in shares of CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares during the last quarter. Asset Dedication LLC raised its holdings in shares of CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after buying an additional 170 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. lifted its position in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Down 0.8 %

Shares of NASDAQ:CME opened at $223.61 on Monday. The company has a 50 day moving average price of $220.69 and a two-hundred day moving average price of $209.49. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $80.52 billion, a PE ratio of 23.51, a PEG ratio of 5.67 and a beta of 0.55. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.36.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company’s revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.25 earnings per share. Analysts forecast that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is currently 48.37%.

Insider Activity

In related news, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares in the company, valued at $6,131,291.92. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sunil Cutinho sold 4,500 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the transaction, the insider now owns 27,053 shares of the company’s stock, valued at $6,131,291.92. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,221 shares of company stock worth $3,351,895 over the last quarter. 0.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on CME shares. Bank of America boosted their target price on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Citigroup increased their price objective on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research report on Thursday, October 24th. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research report on Thursday, October 24th. Barclays raised their price target on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Finally, The Goldman Sachs Group boosted their price objective on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $222.73.

Get Our Latest Stock Report on CME Group

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.